115 related articles for article (PubMed ID: 3238054)
1. Neuropeptide Y and control of vascular resistance in skeletal muscle.
Revington M; McCloskey DI
Regul Pept; 1988 Dec; 23(3):331-42. PubMed ID: 3238054
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
Pernow J; Kahan T; Lundberg JM
Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
4. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
Otani N; Yang T; Levy MN
Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man.
Pernow J; Ohlén A; Hökfelt T; Nilsson O; Lundberg JM
Regul Pept; 1987 Dec; 19(5-6):313-24. PubMed ID: 3438489
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
Modin A; Pernow J; Lundberg JM
Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
Modin A; Pernow J; Lundberg JM
Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
[TBL] [Abstract][Full Text] [Related]
8. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
9. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
Chujo M; Mori H; Tanaka E; Nakazawa H; Okino H
Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
[TBL] [Abstract][Full Text] [Related]
11. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
[TBL] [Abstract][Full Text] [Related]
12. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
Hieble JP; Duesler JG; Daly RN
J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
[TBL] [Abstract][Full Text] [Related]
13. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
Franco-Cereceda A; Matran R; Alving K; Lundberg JM
Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
[TBL] [Abstract][Full Text] [Related]
19. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
20. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
